Home
Archives
Jerusalem Center Homepage
View the current issue
Jerusalem Center Videos
Additional Resources
Top Commentators:
- Elliott Abrams
- Fouad Ajami
- Shlomo Avineri
- Benny Avni
- Alan Dershowitz
- Jackson Diehl
- Dore Gold
- Daniel Gordis
- Tom Gross
- Jonathan Halevy
- David Ignatius
- Pinchas Inbari
- Jeff Jacoby
- Efraim Karsh
- Mordechai Kedar
- Charles Krauthammer
- Emily Landau
- David Makovsky
- Aaron David Miller
- Benny Morris
- Jacques Neriah
- Marty Peretz
- Melanie Phillips
- Daniel Pipes
- Harold Rhode
- Gary Rosenblatt
- Jennifer Rubin
- David Schenkar
- Shimon Shapira
- Jonathan Spyer
- Gerald Steinberg
- Bret Stephens
- Amir Taheri
- Josh Teitelbaum
- Khaled Abu Toameh
- Jonathan Tobin
- Michael Totten
- Michael Young
- Mort Zuckerman
Think Tanks:
- American Enterprise Institute
- Brookings Institution
- Center for Security Policy
- Council on Foreign Relations
- Heritage Foundation
- Hudson Institute
- Institute for Contemporary Affairs
- Institute for Counter-Terrorism
- Institute for Global Jewish Affairs
- Institute for National Security Studies
- Institute for Science and Intl. Security
- Intelligence and Terrorism Information Center
- Investigative Project
- Jerusalem Center for Public Affairs
- RAND Corporation
- Saban Center for Middle East Policy
- Shalem Center
- Washington Institute for Near East Policy
Media:
- CAMERA
- Daily Alert
- Jewish Political Studies Review
- MEMRI
- NGO Monitor
- Palestinian Media Watch
- The Israel Project
- YouTube
Government:
Back
(Jewish News-UK) Sir Eric Pickles, a former chair of the Conservative Party, asked Parliamentary Under-Secretary of State for Health David Mowat about the cost to the government if "Israeli-owned and Israeli-based companies were banned from supplying generic medicines to the National Health Service." Mowat replied that over 100 million prescriptions for medicines are from companies based in Israel. "Banning these supplies would most likely cause significant shortages of some medicines important for patient health, and have a significant impact on competition and in all likelihood increase prices paid by the NHS."2016-09-21 00:00:00Full Article
UK Pharmacy Minister: Israel Boycotts Put 100 Million Prescriptions at Risk
(Jewish News-UK) Sir Eric Pickles, a former chair of the Conservative Party, asked Parliamentary Under-Secretary of State for Health David Mowat about the cost to the government if "Israeli-owned and Israeli-based companies were banned from supplying generic medicines to the National Health Service." Mowat replied that over 100 million prescriptions for medicines are from companies based in Israel. "Banning these supplies would most likely cause significant shortages of some medicines important for patient health, and have a significant impact on competition and in all likelihood increase prices paid by the NHS."2016-09-21 00:00:00Full Article
Search Daily Alert
|
Search:
|